Adrian B. Van Bakel M.D., Ph.D.

Accepting New Patients

Accepting New Patients

Provider Image
3 day(s) until next new
patient appointment as of
8:30 a.m. .

What is this?

  • Professor
  • Medical Director, Cardiac Transplant Program
Degree M.D., Ph.D.
School University of Louisville School of Medicine
  • Medical University of South Carolina
  • University of Utah in Transplant Cardiology
  • Medical University of South Carolina
Board Certification
  • Internal Medicine
  • Internal Medicine: Cardiovascular Disease
  • Cardiology - Heart Failure & Transplant
  • Cardiology
Accepts New Patients Yes
3 day(s) until next new
patient appointment as of
8:30 a.m. 9/30/2016.

What is this?

To request an appointment call our representatives at 843-792-1414


Ashley River Tower
25 Courtenay Drive
Charleston, SC 29425
Map & Directions


Dr. Van Bakel graduated from the University of Louisville School Of Medicine in 1981, completing a Ph.D. in Pharmacology from that institution in 1983. He completed Internal Medicine Residency and Cardiology Fellowship training at the Medical University of South Carolina and has been on the faculty at MUSC since 1991.

He has served as the Medical Director of the Heart Failure and Cardiac Transplant Program since 1991 and has been an integral part of a clinical team that has achieved excellent results in the areas of clinical heart failure management and cardiac transplantation.

Dr. Van Bakel is a member of a number of professional societies including The American College of Physicians, The American Heart Association, The American College of Cardiology, The Heart Failure Society of America and The International Society of Heart and Lung Transplantation. He has served as a manuscript reviewer for several journals including The Journal of Cardiac Failure, The Journal of Heart and Lung Transplantation and The American Journal of Transplantation.

Dr. Van Bakel has been the principal investigator of many multi-center clinical trials in congestive heart failure and cardiac transplantation. His research interests include congestive heart failure management, novel immunosuppression strategies and the pharmacogenomics of drug absorption and metabolism.